|
Predictors
|
aCrude HR (95% CI)
|
bAdjusted HR (95% CI)
|
|---|
|
Sex
|
|
Female
|
1.00
|
1.00
|
|
Male
|
1.27 (1.02–1.60)
|
1.68 (1.19–2.37)
|
|
Preoperative carcino-embryonic antigen (CEA) level
|
|
Not elevated
|
1.00
|
1.00
|
|
Elevated
|
2.03 (1.55–2.65)
|
2.09 (1.39–2.37)
|
|
Duke’s stages
|
|
A&B
|
1.00
|
1.00
|
|
C
|
1.27 (0.89–1.80)
|
1.16 (0.79–1.72)
|
|
D
|
3.98 (2.37–5.80)
|
3.97 (2.59–6.10)
|
|
Tumour grades
|
|
Low
|
1.00
|
1.00
|
|
High
|
2.99 (1.92–4.67)
|
2.91 (1.65–5.14)
|
-
HR hazard ratio, CI confidence interval
-
aUnivariate Cox Proportional Hazard Regression analysis
-
bMultivariate Cox Proportional Hazard Regression analysis, adjusted for age, gender, co- morbidities (diabetes mellitus, hypertension), tumour grade and treatment modalities
